Nahla A. Farag

685 total citations
24 papers, 551 citations indexed

About

Nahla A. Farag is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Nahla A. Farag has authored 24 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 10 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Nahla A. Farag's work include Synthesis and biological activity (11 papers), Click Chemistry and Applications (4 papers) and Quinazolinone synthesis and applications (4 papers). Nahla A. Farag is often cited by papers focused on Synthesis and biological activity (11 papers), Click Chemistry and Applications (4 papers) and Quinazolinone synthesis and applications (4 papers). Nahla A. Farag collaborates with scholars based in Egypt, United States and Czechia. Nahla A. Farag's co-authors include Khaled A. M. Abouzid, Mona F. Schaalan, Hanan S. El‐Abhar, Mohamed M. Elmazar, Gamal A. Soliman, Amal A.M. Eissa, Deena S. Lasheen, Gamal El‐Din A. Abuo‐Rahma, Mohamed Abdel‐Aziz and Tamer S. Kaoud and has published in prestigious journals such as PLoS ONE, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Nahla A. Farag

22 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nahla A. Farag Egypt	13	335	229	81	69	56	24	551
Xing‐Kai Qian China	15	144 0.4×	244 1.1×	108 1.3×	80 1.2×	63 1.1×	31	568
Rajaram Azad India	13	261 0.8×	188 0.8×	70 0.9×	34 0.5×	19 0.3×	23	462
Asmaa M. AboulMagd Egypt	16	356 1.1×	264 1.2×	107 1.3×	90 1.3×	20 0.4×	47	735
Denis A. Babkov Russia	15	369 1.1×	272 1.2×	64 0.8×	44 0.6×	94 1.7×	76	698
Tahsin F. Kellici Greece	15	131 0.4×	238 1.0×	58 0.7×	35 0.5×	42 0.8×	34	548
N. R. Thimmegowda India	16	335 1.0×	234 1.0×	80 1.0×	52 0.8×	21 0.4×	32	686
Deepika Saini India	12	321 1.0×	162 0.7×	46 0.6×	30 0.4×	29 0.5×	26	595
Gui‐Fu Dai China	15	196 0.6×	220 1.0×	64 0.8×	42 0.6×	32 0.6×	30	588
Amal Alharbi Saudi Arabia	12	273 0.8×	272 1.2×	53 0.7×	48 0.7×	13 0.2×	22	486
Pinghua Sun China	15	167 0.5×	239 1.0×	50 0.6×	32 0.5×	27 0.5×	42	555

Countries citing papers authored by Nahla A. Farag

Since Specialization

Citations

This map shows the geographic impact of Nahla A. Farag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nahla A. Farag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nahla A. Farag more than expected).

Fields of papers citing papers by Nahla A. Farag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nahla A. Farag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nahla A. Farag. The network helps show where Nahla A. Farag may publish in the future.

Co-authorship network of co-authors of Nahla A. Farag

This figure shows the co-authorship network connecting the top 25 collaborators of Nahla A. Farag. A scholar is included among the top collaborators of Nahla A. Farag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nahla A. Farag. Nahla A. Farag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

El‐Badawy, Mohamed F., et al.. (2025). Ligand-based discovery of novel N-arylpyrrole derivatives as broad-spectrum antimicrobial agents with antibiofilm and anti-virulence activity. Journal of Enzyme Inhibition and Medicinal Chemistry. 40(1). 2523970–2523970.

Abouzid, Khaled A. M., et al.. (2024). Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations. BMC Chemistry. 18(1). 14–14. 6 indexed citations

Mohamed, Khaled O., et al.. (2023). Novel indolyl 1,2,4-triazole derivatives as potential anti-proliferative agents: in silico studies, synthesis, and biological evaluation. RSC Medicinal Chemistry. 15(1). 293–308. 8 indexed citations

Abou‐Seri, Sahar M., et al.. (2022). Lead generation of cysteine based mesenchymal epithelial transition (c-Met) kinase inhibitors: Using structure-based scaffold hopping, 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamics simulation. Computers in Biology and Medicine. 146. 105526–105526. 8 indexed citations

Elshaier, Yaseen A. M. M., et al.. (2020). Design and synthesis of pyrazolo[3,4-d]pyrimidinone derivatives: Discovery of selective phosphodiesterase-5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(16). 127337–127337. 18 indexed citations

Farag, Nahla A., et al.. (2020). Design, synthesis, and biological evaluation of new pyrazoloquinazoline derivatives as dual COX‐2/5‐LOX inhibitors. Archiv der Pharmazie. 353(11). e2000027–e2000027. 25 indexed citations

Lasheen, Deena S., et al.. (2019). 3D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors: Design, synthesis and biological evaluation. Bioorganic Chemistry. 89. 102988–102988. 39 indexed citations

Hassan, Ghaneya S., et al.. (2016). DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NEW SUCCINIMIDE, 2-IMINOTHIAZOLINE AND OXAZINE DERIVATIVES BASED BENZOPYRONE AS ANTICONVULSANT AGENTS. International Journal of Pharmacy and Pharmaceutical Sciences. 8(4). 222–228. 8 indexed citations

Galanis, Athanasios, Zainab M. Doctor, Raymond M. Paranal, et al.. (2016). Toward discovery of mutant EGFR inhibitors; Design, synthesis and in vitro biological evaluation of potent 4-arylamino-6-ureido and thioureido-quinazoline derivatives. Bioorganic & Medicinal Chemistry. 24(16). 3501–3512. 49 indexed citations

10.

Farag, Nahla A., et al.. (2014). Design, synthesis, 3D pharmacophore, QSAR, and docking studies of carboxylic acid derivatives as Histone Deacetylase inhibitors and cytotoxic agents. Bioorganic Chemistry. 57. 65–82. 34 indexed citations

11.

Abuo‐Rahma, Gamal El‐Din A., Mohamed Abdel‐Aziz, Nahla A. Farag, & Tamer S. Kaoud. (2014). Novel 1-[4-(Aminosulfonyl)phenyl]-1H-1,2,4-triazole derivatives with remarkable selective COX-2 inhibition: Design, synthesis, molecular docking, anti-inflammatory and ulcerogenicity studies. European Journal of Medicinal Chemistry. 83. 398–408. 45 indexed citations

12.

Elmazar, Mohamed M., Hanan S. El‐Abhar, Mona F. Schaalan, & Nahla A. Farag. (2013). Phytol/Phytanic Acid and Insulin Resistance: Potential Role of Phytanic Acid Proven by Docking Simulation and Modulation of Biochemical Alterations. PLoS ONE. 8(1). e45638–e45638. 105 indexed citations

13.

Farag, Nahla A., et al.. (2012). Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors. European Journal of Medicinal Chemistry. 61. 132–145. 42 indexed citations

14.

Hassan, Ghaneya S., et al.. (2011). Design, Synthesis, and Docking Studies of Novel Diarylpyrazoline and Diarylisoxazoline Derivatives of Expected Anti-inflammatory, and Analgesic Activities. 8(1).

15.

Abou‐Seri, Sahar M., Nahla A. Farag, & Ghaneya S. Hassan. (2011). Novel Diphenylamine 2,4'-Dicarboxamide Based Azoles as Potential Epidermal Growth Factor Receptor Inhibitors: Synthesis and Biological Activity. Chemical and Pharmaceutical Bulletin. 59(9). 1124–1132. 9 indexed citations

16.

Eissa, Amal A.M., Nahla A. Farag, & Gamal A. Soliman. (2009). Synthesis, biological evaluation and docking studies of novel benzopyranone congeners for their expected activity as anti-inflammatory, analgesic and antipyretic agents. Bioorganic & Medicinal Chemistry. 17(14). 5059–5070. 45 indexed citations

17.

Farag, Nahla A., et al.. (2009). Design, synthesis and docking studies of new furobenzopyranones and pyranobenzopyranones as photoreagent towards DNA and as antimicrobial agents. European Journal of Medicinal Chemistry. 45(1). 317–325. 20 indexed citations

18.

Farag, Nahla A., et al.. (2008). Design, synthesis, and docking studies of novel benzopyrone derivatives as H1-antihistaminic agents. Bioorganic & Medicinal Chemistry. 16(19). 9009–9017. 15 indexed citations

19.

Farag, Nahla A.. (2008). Tetrahydrobenzo- and benzofurobenzopyrones as a new class of potential photoreagents toward DNA. European Journal of Medicinal Chemistry. 44(1). 18–24. 5 indexed citations

20.

Hassan, Ghaneya S., et al.. (2008). Design and Synthesis of Novel Benzopyran‐2‐one Derivatives of Expected Antimicrobial Activity through DNA Gyrase‐B Inhibition. Archiv der Pharmazie. 341(11). 725–733. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact